Congratulations to Kanchan Relwani, M.D., Head of Medical Affairs, for being recognized as our 2022 Healthcare Businesswomen’s Association Luminary – a testament to her role as a mentor and leader.
See what our valued co-leaders have to say about our employee resource group for LGBTQ+ employees and allies.
Alkermes worked with The Harris Poll to gather psychiatrists’ insights and perspectives on caring for people living with bipolar I disorder.
Alkermes' Head of Human Resources Steve Schiavo reflects on our employees' commitment during the COVID-19 pandemic.
Learn more about our ongoing clinical development program for nemvaleukin alfa, our lead immuno-oncology candidate.
As the unmet medical need in oncology changes, Alkermes is using its R&D capabilities honed over 30 years of work on complex diseases to investigate a potential next breakthrough in cancer therapy.
Alkermes employees seek to make a positive impact in their communities by taking part in Alkermes in Action, our employee-led volunteer program that represents our commitment to giving back to our loc
In a recent interview with Informa Connect's Xconomy, our Chief Operating Officer, Blair Jackson, discusses our ambitions and our evolving strategy in neuroscience and oncology.
Senior Director and Research Oncology Program Lead Heather Losey, Ph.D. shares five leadership lessons she’s learned throughout her career as part of an Authority Magazine series highlighting inspirat
We hosted a webcast in June 2021 with expert oncologists and ARTISTRY clinical program investigators to review data updates presented at the 2021 ASCO Annual Meeting.
We’re proud to recognize Joyanna Wesche-Blake, Senior Director of IT, as our 2021 Healthcare Businesswomen’s Association (HBA) Rising Star – a testament to her leadership and commitment to excellence.
We hosted a virtual Investor Day in March 2021 to discuss our research and development strategy and portfolio, including updates from our nemvaleukin alfa development program in immuno-oncology and ne
In this “The Medicine Maker” article, our Chief Operating Officer, Blair Jackson, discusses how to determine corporate readiness when exploring a new therapeutic area and reflects on Alkermes' entry i
Alkermes worked with The Harris Poll to conduct a survey exploring drinking patterns during the COVID-19 pandemic and people’s motivations to seek help.